'Satiety hormone' leptin links obesity to high blood pressure
2014-12-04
(Press-News.org) Leptin, a hormone that regulates the amount of fat stored in the body, also drives the increase in blood pressure that occurs with weight gain, according to researchers from Monash University and the University of Cambridge.
Being obese or overweight is a major risk factor for the development of high blood pressure and cardiovascular disease. Whilst a number of factors may be involved, the precise explanation for the link between these two conditions has been unclear.
In a study published today in the journal Cell, a research team led by Professor Michael Cowley, Monash University, Australia, in collaboration with Professor Sadaf Farooqi, from the University of Cambridge, UK, studied mice and humans who have problems producing or processing the hormone leptin and compared them with 'healthy' individuals to see whether this hormone could provide the link. Leptin is made by fat and circulates in the bloodstream to reach the brain, where it acts as a signal for energy reserves, adjusting both energy expenditure and the sensation of hunger - hence it is sometimes referred to as the 'satiety hormone'.
The group showed that some obese people who were lacking the hormone leptin because of a genetic disorder had low blood pressure despite being very heavy. This was also the case for people lacking the gene for the leptin receptor in the brain, meaning that the brain was unable to respond to the hormone.
Modelling the human condition, Professor Cowley's team in Australia showed that mice with normal leptin signalling developed an increase in blood pressure when they became obese on a high fat diet. These effects were not seen in mice that lacked leptin or where leptin was unable to work because of a defect or block on the leptin receptor.
These experiments demonstrate that leptin signalling is necessary for obesity-induced increased blood pressure. The clinical studies in severely obese humans showed that these observations are relevant to humans.
Professor Cowley said: "High blood pressure is a well-known consequence of obesity. Our study explains the mechanism behind this link, showing that leptin, a hormone secreted by fat, increases blood pressure."
The researchers are now investigating the precise pathways in the brain by which leptin acts to regulate blood pressure.
Professor Farooqi, from the Wellcome Trust-Medical Research Council Institute of Metabolic Science, added: "We now know that leptin regulates both our weight and our blood pressure through its action on the brain. Targeting this action could offer a useful way of helping people fight obesity and associated problems such as high blood pressure and heart disease."
INFORMATION:
This work was supported in Australia by the Heart Foundation of Australia, The National Health and Medical Research Council of Australia, Monash University and Pfizer Australia; and in the UK by the Wellcome Trust, the Medical Research Council, NIHR Cambridge Biomedical Research Centre and the Bernard Wolfe Health Neuroscience Fund.
ELSE PRESS RELEASES FROM THIS DATE:
2014-12-04
PHILADELPHIA--People with mental illness are more likely to have been tested for HIV than those without mental illness, according to a new study from a team of researchers at Penn Medicine and the U.S. Centers for Disease Control and Prevention (CDC) published online this week in AIDS Patient Care and STDs. The researchers also found that the most seriously ill - those with schizophrenia and bipolar disease - had the highest rate of HIV testing.
The study assessed nationally representative data from 21,785 adult respondents from the 2007 National Health Interview Survey ...
2014-12-04
EAST LANSING, Mich. - Take two poisonous mushrooms, and call me in the morning. While no doctor would ever write this prescription, toxic fungi may hold the secrets to tackling deadly diseases.
A team of Michigan State University scientists has discovered an enzyme that is the key to the lethal potency of poisonous mushrooms. The results, published in the current issue of the journal Chemistry and Biology, reveal the enzyme's ability to create the mushroom's molecules that harbor missile-like proficiency in attacking and annihilating a single vulnerable target in the ...
2014-12-04
Some National Football League (NFL) players have been seeking out unproven stem cell therapies to help accelerate recoveries from injuries, according to a new paper from Rice University's Baker Institute for Public Policy. While most players seem to receive treatment within the United States, several have traveled abroad for therapies unavailable domestically and may be unaware of the risks involved, the paper found.
The paper is published in the 2014 World Stem Cell Report, which is a special supplement to the journal Stem Cells and Development and is the official publication ...
2014-12-04
Today's smartphones are designed to entertain and are increasingly marketed to young adults as leisure devices. Not surprisingly, research suggests that young adults most often use their phones for entertainment purposes rather than for school or work.
With this in mind, three Kent State University researchers, Andrew Lepp, Ph.D., Jacob Barkley, Ph.D. and Jian Li, Ph.D., and a Kent State graduate student, Saba Salehi-Esfahani, surveyed a random sample of 454 college students to examine how different types of cell phone users experience daily leisure.
The trio from ...
2014-12-04
Boston, MA - A study published this week in Genetics in Medicine is the first to explore new parents' attitudes toward newborn genomic testing. The findings suggest that if newborn genomic testing becomes available, there would be robust interest among new parents, regardless of their demographic background.
The study, led by researchers at Brigham and Women's Hospital (BWH) and Boston Children's Hospital, found that the majority of parents surveyed were interested in newborn genomic testing.
As next-generation whole-exome and genome sequencing is integrated into clinical ...
2014-12-04
TORONTO, Dec. 4, 2014 - Results from an ongoing survey conducted by the Centre for Addiction and Mental Health (CAMH) show that 2.2 per cent of adults --or over 230,000 people in Ontario, Canada -- seriously contemplated suicide in the last year. The 2013 edition of the CAMH Monitor, released today, included questions about suicidal ideation for the first time in the survey's history.
"Suicide is a major public health issue, and these data confirm that large numbers of Ontario adults report having suicidal thoughts," said Dr. Hayley Hamilton, CAMH scientist and co-principal ...
2014-12-04
Insecticides aimed at controlling early-season crop pests, such as soil-dwelling grubs and maggots, can increase slug populations, thus reducing crop yields, according to researchers at Penn State and the University of South Florida.
"Neonicotinoids are the most widely used insecticides in the world," said Margaret Douglas, graduate student in entomology, Penn State. "Seed applications of neonicotinoids are often viewed as cheap insurance against pest problems, but our results suggest that they can sometimes worsen pest problems and should be used with care."
According ...
2014-12-04
GAINESVILLE, Fla. -- It's no secret that low-birth-weight babies face significantly greater risks for certain health problems early on, such as respiratory distress or infection. Now, a new study from researchers at the University of Florida and Northwestern University shows that lower weights at birth also have an adverse effect on children's performance in school, which is likely due to the early health struggles small babies often face.
Using a unique set of data that matched birth and school records from 1.6 million children born in Florida between 1992 and 2002, ...
2014-12-04
Nalmefene (trade name Selincro) has been approved since February 2013 for people with alcohol dependence who currently drink a lot of alcohol, but who do not have physical withdrawal symptoms and who do not require immediate detoxification. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether the drug offers an added benefit over the appropriate comparator therapy in this patient group.
According to the findings, such an added benefit is not proven: In its dossier, the drug manufacturer only presented data for ...
2014-12-04
A study published in the New England Journal of Medicine reveals the role of a receptor protein derived from a gene that has been linked to human growth. Co-author Stefano Costanzi, Ph.D., an assistant professor of biochemistry at American University, developed the three-dimensional computer model of the receptor that appears in the study.
"As the study reveals the receptor's role in growth, it may ultimately lead to the development of drugs to treat those affected with conditions that alter growth, such as gigantism or dwarfism," Costanzi said. "The construction of the ...
LAST 30 PRESS RELEASES:
[Press-News.org] 'Satiety hormone' leptin links obesity to high blood pressure